Table 1.

Baseline characteristics at time of initial diagnosis

PatientSexAge (yr)Earliest Available eGFR (ml/min per 1.73 m2)Proteinuria (g/d or g/g creatinine)Immunosuppressive TreatmentOutcome
1M3791.5CorticosteroidsCR
2M369515Corticosteroids, cyclosporine, rituximabPR
3M489624.0Corticosteroids, cyclophosphamide (PO and IV)CR
4M2549UnknownCorticosteroids, mycophenolate mofetilCR
5F2711012.0CorticosteroidsCR
6F1590UnknownCorticosteroidsCR
7M3780UnknownNoneCR
8M1877UnknownCorticosteroidsPR
9F4626UnknownCyclosporineCR
10M47936.0NoneCR
11M52286.2Corticosteroids, cyclophosphamide (PO)PR
12F3138UnknownCorticosteroidsPR
13M199716.9Corticosteroids, cyclosporinePR
14F4453UnknownCorticosteroids, mycophenolate mofetil, cyclosporine, rituximabPR
15M61597.0CorticosteroidsCR
16M608110.5Cyclosporine, mycophenolate mofetil, cyclophosphamideCR
  • M, male; CR, complete remission; PR, partial remission; PO, by mouth; IV, intravenous; F, female.